Masimo Corporation (MASI)
NASDAQ: MASI · Real-Time Price · USD
143.96
-2.53 (-1.73%)
At close: Nov 26, 2025, 4:00 PM EST
146.31
+2.35 (1.63%)
After-hours: Nov 26, 2025, 7:38 PM EST
Masimo Revenue
Masimo had revenue of $371.50M in the quarter ending September 27, 2025, with 8.21% growth. This brings the company's revenue in the last twelve months to $2.18B, up 38.48% year-over-year. In the year 2024, Masimo had annual revenue of $2.09B with 2.26% growth.
Revenue (ttm)
$2.18B
Revenue Growth
+38.48%
P/S Ratio
3.56
Revenue / Employee
$606,111
Employees
3,600
Market Cap
7.73B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 28, 2024 | 2.09B | 46.30M | 2.26% |
| Dec 30, 2023 | 2.05B | 12.30M | 0.60% |
| Dec 31, 2022 | 2.04B | 796.60M | 64.28% |
| Jan 1, 2022 | 1.24B | 95.50M | 8.35% |
| Jan 2, 2021 | 1.14B | 205.86M | 21.95% |
| Dec 28, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 29, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jan 2, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
MASI News
- 9 days ago - Knobbe Martens Guides Masimo to $634M Win Against Apple in Patent Infringement Case - PRNewsWire
- 10 days ago - DRC Congratulates Knobbe Martens on its $634 Million Win for Masimo - GlobeNewsWire
- 11 days ago - 4D Advisors Offloads $7.6 Million in Masimo (MASI) Stock, Selling 45,000 Shares - The Motley Fool
- 12 days ago - Jury says Apple owes Masimo $634M for patent infringement - TechCrunch
- 13 days ago - US jury says Apple must pay Masimo $634 million in smartwatch patent case - Reuters
- 13 days ago - Masimo Issues Statement on California Jury Verdict Finding Patent Infringement by Apple and Awarding Masimo $634 Million in Damages - Business Wire
- 23 days ago - Masimo Corporation (MASI) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 23 days ago - Masimo Reports Third Quarter 2025 Results - Business Wire